Abstract
Diabetes is an important risk factor for severe coronavirus disease 2019 (COVID-19), but little is known about the marginal effect of additional risk factors for severe COVID-19 among individuals with diabetes. We tested the hypothesis that sociodemographic, access to health care, and presentation to care characteristics among individuals with diabetes in Mexico confer an additional risk of hospitalization with COVID-19. We conducted a cross-sectional study using public data from the General Directorate of Epidemiology of the Mexican Ministry of Health. We included individuals with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 between 1 March and 31 July 2020. The primary outcome was the predicted probability of hospitalization, inclusive of 8.5% of patients who required intensive care unit admission. Among 373,963 adults with COVID-19, 16.1% (95% CI 16.0-16.3) self-reported diabetes. The predicted probability of hospitalization was 38.4% (37.6-39.2) for patients with diabetes only and 42.9% (42.2-43.7) for patients with diabetes and one or more comorbidities (obesity, hypertension, cardiovascular disease, and chronic kidney disease). High municipality-level of social deprivation and low state-level healt...Continue Reading
References
May 2, 2007·Salud pública de México·Julio FrenkFelicia Marie Knaul
Mar 24, 2009·The Journal of Ambulatory Care Management·Andrea PuigRebeca Wong
Aug 4, 2009·Bulletin of the World Health Organization·Julio FrenkFelicia Marie Knaul
Feb 5, 2013·Globalization and Health·Simon BarqueraJuan Rivera-Dommarco
Feb 6, 2014·Menopause : the Journal of the North American Menopause Society·Jody M JacksonKaren L Margolis
Jul 20, 2014·Primary Care Diabetes·Silvia PastorinoUNKNOWN National Survey of Health and Development Scientific and Data Collection Teams
Mar 18, 2016·Current Medical Research and Opinion·Kristy IglaySwapnil Rajpathak
Dec 14, 2016·The New England Journal of Medicine·Jesus Alegre-DíazJonathan R Emberson
Jul 28, 2018·PloS One·Juan Pablo GutierrezBelkis M Aracena
Dec 14, 2018·Health Policy and Planning·Svetlana V DoubovaClaudia Infante-Castañeda
Jan 22, 2019·Lancet·Julio FrenkFelicia Marie Knaul
Dec 24, 2019·Salud pública de México·Ana Basto-AbreuSalvador Villalpando
May 6, 2020·Cell Metabolism·Lihua ZhuHongliang Li
May 16, 2020·Diabetes Care·Qiao ShiWeixing Wang
May 16, 2020·Diabetes Care·Matthew C RiddleSteven E Kahn
May 24, 2020·BMJ : British Medical Journal·Christopher M PetrilliLeora I Horwitz
Jun 1, 2020·The Journal of Clinical Endocrinology and Metabolism·Omar Yaxmehen Bello-ChavollaCarlos A Aguilar-Salinas
Jun 14, 2020·Science·Patrick G T WalkerAzra C Ghani
Aug 5, 2020·Archives of Medical Research·Diego Rolando Hernández-GaldamezPablo Méndez-Hernández
Aug 28, 2020·Diabetes Care·Jacqueline SeiglieJennifer Manne-Goehler
Oct 9, 2020·PloS One·Juan Pablo Gutierrez, Stefano M Bertozzi
Citations
Feb 3, 2021·Cell Metabolism·Daniel J Drucker
Feb 3, 2021·Nature Medicine·Jacqueline A SeiglieJ Jaime Miranda
Jun 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Manuel Jiménez-EstradaAna Berenice Alvarez